VITREOLENT

This brand name is authorized in Poland

Active ingredients

The drug VITREOLENT contains a combination of these active pharmaceutical ingredients (APIs):

1 Potassium iodide
UNII 1C4QK22F9J - POTASSIUM IODIDE

Potassium iodide is indicated as a thyroid-blocking agent to prevent the uptake of radioactive iodine, for example after a nuclear accident or during a nuclear medicine investigation before administering a radioiodinated compound, which is metabolised to iodide or which contains radioiodine impurities.

Read about Potassium iodide
2 Sodium iodide
UNII F5WR8N145C - SODIUM IODIDE

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
S01XA Other ophthalmologicals S Sensory organs → S01 Ophthalmologicals → S01X Other ophthalmologicals
Discover more medicines within S01XA

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100071497

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈